Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)
OTCMKTS · Delayed Price · Currency is USD
9.36
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

Shin Nippon Biomedical Laboratories Company Description

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies.

The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels.

In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants.

Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.

Shin Nippon Biomedical Laboratories, Ltd.
CountryJapan
Founded1957
IndustryDiagnostics & Research
SectorHealthcare
Employees1,531
CEORyoichi Nagata

Contact Details

Address:
2438 Miyanoura-cho
Kagoshima, 891-1394
Japan
Phone81 9 9294 2600
Websitesnbl.co.jp

Stock Details

Ticker SymbolSBLOF
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
SIC Code8731

Key Executives

NamePosition
Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D.President, Chairman, Chief Executive Officer, Group Chief Financial Officer, Fisheries Business Officer and Chief Health Officer
Fumihiko MakinoSenior Executive Officer, Financial Controller and GM of Finance and Accounting
Toshiyuki IwataManaging Executive Officer, R/PR Division Manager and Sustainability Officer
Shinji NitandaSenior MD of Corporate Development and Corporate Tax Administration and Director
Kyomi NagatoshiSenior Managing Executive Officer, Head of General Affairs and Human Resources and Director
Ken Takanashi CPA, MBA.Executive Vice President of Group Corporate Management and Global Business & Director
Satoshi MatsumotoManaging Executive Officer and GM of Fisheries Division
Dr. Hideshi Tsusaki DVM Ph.D.Senior MD, President of Non-Clinical and Global Business Development and Director
Terumasa HiraiManaging Executive Officer and President and Representative Director of SNBL Ina Research Center
Dr. Shu-Ichi Kanazashi M.D., Ph.D.Managing Executive Officer, CMO and General Manager of TR Business Division